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Abstract The formation of dendritic arbors in neurons is a
highly regulated process. Among the regulators of
dendritogenesis are numerous membrane proteins that are
eventually internalized via clathrin-mediated endocytosis.
AP2 is an adaptor complex that is responsible for recruiting
endocytic machinery to internalized cargo. Its direct involve-
ment in dendritogenesis in mammalian neurons has not yet
been tested. We found that the knockdown of AP2b1 (β2-
adaptin), an AP2 subunit, reduced the number of dendrites
in developing rat hippocampal neurons and decreased α-ami-
no-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptor subunit GluA2 levels by inhibiting mechanistic/
mammalian target of rapamycin (mTOR). The dendritic tree
abruption that was caused by AP2b1 knockdown was rescued
by the overexpression of GluA2 or restoration of the activity
of the mTOR effector p70S6 kinase (S6K1). Altogether, this
work provides evidence that the AP2 adaptor complex is
needed for the dendritogenesis of mammalian neurons and
reveals that mTOR-dependent GluA2 biosynthesis contributes
to this process.
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Introduction
Classes of neurons with different functions have unique
shapes of dendritic arbors to ensure the accurate responses
of neurons to information they receive [1]. The multistep
process of dendritic tree development is tightly regulated
by various extracellular and intracellular factors [2–4], but
cross-talk between various factors during dendritogenesis
has been scarcely investigated.
Clathrin-mediated endocytosis (CME) enables (i) a variety
of molecules to enter a cell upon ligand–receptor interactions,
(ii) the control of signal transduction that is initiated by these
interactions, and, (iii) in the case of neurons, the control of
synaptic transmission. In CME, the intake of cargo occurs via
membranous clathrin-coated pit with the help of a wide range
of accessory adaptor proteins, including the AP2 adaptor com-
plex [5]. AP2 is composed of four subunits: AP2a1 (α1-
adaptin)/AP2a2 (α2-adaptin), AP2b1 (β2-adaptin), AP2m1
(adaptin-μ2), and AP2s1 (σ2-adaptin). These subunits bind
cargo (AP2b1 and AP2m1), the plasma membrane (AP2a1/2
and AP2m1), clathrin, and other accessory proteins (e.g., Eps15
and AP180 [AP2b1]) [6]. CME is utilized by several receptors
that regulate nervous system development and physiology, in-
cludingα-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptors [7–9]. Consequently, CME contributes to
neuronal development (e.g., dendritic growth and pruning;
[10–14] and synaptic plasticity [9]). However, the particular role
of AP2 during dendritogenesis has been scarcely investigated
[12] and, to date, evidence is still lacking concerning the role of
AP2 in mammalian dendritogenesis.
AMPARs mediate fast excitatory transmission in gluta-
matergic synapses in mammals. In the hippocampus,
AMPARs mainly consist of GluA1-GluA2 and GluA2-
GluA3 heterotetramers that can undergo dynamic and fast
redistribution in and out of the plasma membrane, a process
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that contributes to synaptic plasticity in mature neurons
[15–17]. AMPARs interact with AP2. Upon long-term depres-
sion (LTD) induction or the application of N-methyl-D-aspar-
tate (NMDA), AMPARs undergo endocytosis, which requires
this adaptor complex [9]. Less is known about the trafficking
and function of AMPARs in developing neurons. Earlier stud-
ies demonstrated the importance of AMPARs for the growth
of apical dendrites in developing rat cortical neurons in
organotypic in vitro cultures [18] and the experience-
dependent dendritic arbor growth of tectal neurons in
Xenopus laevis in vivo [19].
One important regulator of dendritic arborization is
mechanistic/mammalian target of rapamycin (mTOR;
[20–22]). mTOR is a protein kinase that is known to ad-
just intercellular processes in response to extracellular fac-
tors [23, 24]. In neurons, mTOR complex 1 (mTORC1)
plays a role in the control of protein translation [24, 25].
However, the specific proteins that are translated in an
mTORC1-dependen t fash ion and con t r ibu te to
dendritogenesis remain unknown. Also, the link between
CME and mTORC1 in dendritogenesis has not yet been
thoroughly studied. The present study provides evidence
that this link indeed exists and plays an important role in
regulating the levels of GluA2 in neurons and dendritic
arborization. Specifically, AP2b1 knockdown led to a re-
duction of the number of dendrites in developing rat hip-
pocampal neurons in vitro and in vivo. AP2 deficiency
also resulted in a decrease in the cellular levels of
GluA2, which was not an effect of a disturbance in mem-
brane trafficking or the accelerated degradation of this
protein. Instead, our data indicated that the inhibition of
mTOR-controlled GluA2 expression was a likely cause of
the decrease in GluA2 levels upon AP2 knockdown.
Finally, we found that dendritic tree abruption that was
caused by AP2 knockdown was rescued by the overex-
pression of functional GluA2 subunits or restoration of




The primary antibodies that were used in the present study are
listed in Table 1. Alexa Fluor 488-, 568-, 594-, and 647-
conjugated secondary antibodies (anti-mouse, anti-goat, and
anti-rabbit) were purchased from Invitrogen (Carlsbad, CA).
Horseradish peroxidase-conjugated secondary antibodies and
anti-mouse/anti-rabbit IRDye® 680RD and IRDye® 800CW
were obtained from Jackson ImmunoResearch (West Grove,
PA) and LI-COR Biosciences (Lincoln, NE), respectively.
Rapamycin and cycloheximide were purchased from
Calbiochem (La Jolla, CA) and Sigma-Aldrich (St. Louis,
MO), respectively. NMDA, brain-derived neurotrophic factor
(BDNF), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), and
D-2-amino-5-phosphonopentanoate (AP5) were purchased
from Sigma-Aldrich (St. Louis, MO). AMPA was obtained
from Tocris Bioscience (Minneapolis, MN).
DNA Constructs
The following mammalian expression plasmids were de-
scribed previously: pSuper [26], β-actin-GFP [20], β-actin-
mRFP [27], EFα-β-gal [28], pEGFP-C1 (Clontech, Mountain
View, CA), pGW1 (British Biotechnology, UK), pRK5-
p70S6KT389E (pS6Kca; [29]), pSuper-GluA2sh [30],
pSuper-shAP2b1#1, pSuper-shAP2b1#2, pSuper-
shAP2b1#3 [31], pCMV-VSV-G [32], RSV-Rev, and
pMDLg/pRRE [33]. pUltra-Chili (Addgene plasmid no.
48687) was a gift from Malcolm Moore. Plasmids that
encoded GluA2 and its mutants GluA2ΔC, GluA2Q566R,
and GluA2Q581R were kind gifts from Dr. M. Passafaro
[30, 34] and were used to subclone GluA2-encoding se-
quences to the pGW1 vector. Short-hairpin RNAs (shRNAs)
against rat α-adaptin (GenBank no. NM_001107511) were
designed to target the following sequences: 5′-TCCG
GCTCATTAACAACGCTATC-3′ (shAP2a1#1), 5′-TCCA
GGACTACACTTACTACTTC-3′ (shAP2a1#2), and 5′-
CGGAGACAGCATGGATAGTGTGA-3′ (shAP2a1#3) and
inserted into pSuper. Scrambled shRNAswere designed based
on the original AP2b1 shRNA sequences using the online
siRNA Wizard v3.1 tool and cloned into the pSuper vector.
The fo l lowing sequences were used : 5 ′ -GTCT
CACAACAAGATATGT-3 ′ (scrAP2b1#1), 5 ′-GATC
ATTACCCGTACTATA-3′ (scrAP2b1#2), and 5′-GGGT
GAGATCATGAGAGAA-3′ (scrAP2b1#3). shAP2b1#2 was
additionally subcloned to pUltra-Chili to obtain pUltra-Chili-
shAP2b1. pEGFP-AP2b1 was obtained by subcloning rat
AP2b1 cDNA into EcoRI/SalI sites of pEGFP-C1. pEGFP-
AP2b1*, a plasmid that encodes the shRNA#2-resistant mu-
tant of AP2b1, was generated from pEGFP-AP2b1 by intro-
ducing silent mutations in the shRNA target region using the
QuikChange Site-Directed Mutagenesis System (Stratagene,
Santa Clara, CA) with the following primers: 5′-GATC
AGTGAGTCTCACCCAAACAGTAACCTGCTCGACT
TGAACCCTCAGAATATC - 3 ′ a n d 5 ′ - GATA
TTCTGAGGGTTCAAGTCGAGCAGGTTACTGTTTG
GGTGAGACTCACTGATC -3′. pGW1-GluA2ΔSP was ob-
tained by deleting the N-terminal signal peptide
(MQKIMHISVLLSPVLWGLIFGV) from the wild-type
GluA2 construct according to the protocol of the Q5® Site-
Directed Mutagenesis Kit (New England Biolabs, Ipswich,




Lentiviral Production and Purification
For lentiviral vector production, the pUltra-Chili plasmid or its
derivatives that encoded shRNA were co-transfected to
HEK293T cells with third-generation packing system plas-
mids (pCMV-VSV-G, pRSV-Rev, and pMDLg-pRRE) using
the calcium phosphate method. After 48 h, the medium from
HEK293T cells was filtrated (0.22 μm pore size), aliquoted,
and stored at −80 °C until needed for the in vitro culture
experiments. For in vivo lentiviral vector injections, viral par-
ticles after production in HEK293T cells were additionally
purified and concentrated. To accomplish this, medium from
HEK293Tcells was spun for 5 min at 1600×g at 4 °C, and the
supernatant was filtered using a Filtermax rapid bottle filter
(0.22 μm pore size; TPP Techno Plastic Products AG,
Trasadingen, Switzerland). The medium was then centrifuged
at 110,000×g at 4 °C for 90 min, and the pellet was dissolved
in cold phosphate-buffered saline (PBS) that contained 10 %
glycerol with shaking at 4 °C for 3.5 h. The dissolved pellet
was quickly spun for 30 s at 14,000×g, and the supernatant
was aliquoted and stored at −80 °C.
Neuron Culture, Transfection, and Transduction
To obtain neurons for the tissue culture, pregnant female rats
and rat embryos of both sexes were sacrificed according to a
protocol that was approved by the 1st Ethical Committee in
Warsaw, Poland (decision no. 288/2012), which was in
compliance with European Community Council Directive
86/609/EEC. Primary hippocampal and cortical cultures were
prepared from embryonic day 19 rat brains according to the
procedure of Banker and Goslin [35] with modifications and
transfected on day in vitro (DIV) 0 (cortical) or DIV7
(hippocampal) using Amaxa nucleofection or Lipofectamine
2000 (Invitrogen), respectively, as described previously [36].
For knockdown experiments, hippocampal neurons were co-
transfected with either pSuper or pSuper that encoded the
desired shRNA (or their scrambled counterparts), EFα-β-
gal, and β-actin-GFP/β-actin-mRFP in a 1:1:1 ratio. When
shRNA mix was used instead of single shRNA, it was co-
transfected with β-actin-GFP in a 2:1 ratio. For the rescue
experiments, neurons were co-transfected with pSuper-
shAP2b1#2 or control pSuper, β-actin-GFP, and one of the
following rescue constructs: pEGFP-C1-AP2b1*, pGW1-
GluA2, pGW1-GluA2ΔC, pGW1-GluA2ΔSP, pGW1-
GluA2Q566R, pGW1-GluA2Q581, or EFα-β-gal. The cells
were fixed 72 h after transfection. Lentiviral vectors were
produced as described above, and the resulting filtered super-
natant that contained viral particles was added to DIV4 neu-
rons for 5 h (30 μl/well in a 24-well plate) in the mix of fresh
Neurobasal® medium (Thermo Fisher Scientific, Waltham,
MA, USA) supplemented with 2 % B27 (Thermo Fisher
Scientific), 1 % penicillin-streptomycin (Sigma-Aldrich),
0.5 mM glutamine (Thermo Fisher Scientific), and condi-
tioned culture medium (1:1). After incubation with the virus-
es, the neurons were washed with non-supplemented
Table 1 Primary antibodies used
for the study Antigen Manufacturer Catalog no. Host Application Dilution
CD63 Santa Cruz Biotechnology,
Dallas, TX
H-193 Mouse IF 1:100
GFP Roche Applied Science,
Penzberg, Germany
11814460001 Mouse WB 1:5000
GluA1 EMD Millipore, Billerica,
MA
AB1504 Rabbit WB 1:1000






2855 Rabbit WB 1:250
Phospho-p70 S6
kinase (Thr389)
Cell Signaling Technology 9206 Mouse WB 1:1000
Rab7 Cell Signaling Technology D9572 XP Rabbit IF 1:100
RFP Abcam, Cambridge, UK 62341 Rabbit IHC 1:250
TrkB Cell Signaling Technology 4603 Rabbit WB 1:1000
α-Adaptin BD Biosciences, Franklin
Lakes, NJ
610502 Mouse WB 1:1000
α-tubulin Sigma-Aldrich, St. Louis,
MO
T5168 Mouse WB 1:10,000




Promega, Madison, WI Z3781 Mouse WB 1:1000
IF immunofluorescence, IHC immunohistochemistry, WBWestern blot
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Neurobasal® medium and further cultured in the mix of fresh
Neurobasal® medium (supplemented as described above) and
conditioned culture medium (1:1).
Cell Line Culture and Transfection
RAT2 cells were grown in Dulbecco’s modified Eagle’s me-
dium (DMEM) that contained 10 % fetal bovine serum and
1% penicillin-streptomycin (Sigma-Aldrich) at 37 °C in a 5%
CO2 atmosphere. For the knockdown experiments, the cells
were co-electroporated, using CUY21 device (Nepagene,
Chiba, Japan) according to the manufacturer’s protocol, with
either pSuper or pSuper-shAP2b1#2 and pEGFP-C1 in a 3:1
ratio. After electroporation, the cells were cultured for 48 h in
DMEM with 2 % FBS at 37 °C in a 5 % CO2 atmosphere.
Drug Treatment and Western Blot Analysis
Rapamycin (100 nM) was added to DIV7 hippocampal neu-
rons for 48 h. Cycloheximide (10 μM) was delivered to hip-
pocampal neurons 3 days post-transduction for 24 h. The col-
lected cell lysates were analyzed by Western blot. For quanti-
tative analysis, secondary antibodies conjugated to appropri-
ate IRDyes® and the Odyssey Infrared Imaging System (LI-
COR Biosystems) were used. The results were quantified
using Image Studio™ Lite (LI-COR Biosystems). GluA2
degradation was measured as the ratio of GluA2 levels in
cycloheximide (CHX)-treated cells to control cells in neurons
that were transduced with Lv-Chili-shAP2b1 compared with
Lv-Chili-infected neurons.
Immunofluorescent Labeling of Hippocampal Neurons
Neurons were fixed using 4 % paraformaldehyde/4 %
sucrose in PBS (137 mM NaCl, 2.7 mM KCl, 8 mM
Na2HPO4, and 1.4 mM KH2PO4, pH 7.4) for 15 min at
room temperature, washed three times with PBS, and
incubated with primary antibody diluted in ADB buffer
(1× PBS, 1 % bovine serum albumin [BSA], and 0.3 %
Triton X-100) for GluA2 and CD63 staining or GDB
buffer (30 mM phosphate buffer [pH 7.4], 0.2 % gela-
tin, 0.5 % Triton X-100, and 450 mM NaCl) for AP2b1
staining overnight at 4 °C. On the next day, the cells
were washed three times with PBS and incubated with
appropriate Alexa Fluor-conjugated secondary antibodies
diluted 1:100 in ADB buffer for GluA2 and CD63 and
1:200 in GDB buffer for AP2b1 for 1 h at room tem-
perature. Afterward, the cells were again washed with
PBS, and coverslips were mounted using ProLong®
Gold Antifade Reagent with or without DAPI (Cell
Signaling Technology) or VECTASHIELD Antifade
Mounting Medium (Vector Laboratories, Burlingame,
CA).
Transferrin Uptake Assay
Neurons and RAT2 cells were starved at 37 °C in a 5 % CO2
atmosphere in non-supplemented Neurobasal® medium or
DMEM for 3 and 18 h, respectively. Alexa Fluor® 647-
conjugated transferrin from human serum (Thermo Fisher
Scientific) was then added to the cells for 5 and 10 min at a
final concentration of 25 μg/ml. The cells were then rinsed
with medium, fixed with paraformaldehyde, and washed with
PBS. Afterwards, confocal images of cells were acquired and
fluorescence intensity was analyzed as described below in the
appropriate BMaterials and Methods^ section.
GluA2 Internalization Assay
For the labeling of surface GluA2 receptors and subsequent
analysis of their internalization, live neurons were incubated
Fig. 1 AP2 controls dendritic arbor morphology in neurons cultured
in vitro. a Representative confocal images of DIV10 cultured
hippocampal neurons immunofluorescently stained for AP2b1. Cells
were transfected on DIV8 for 2 days as indicated. Neurons were
additionally co-transfected with GFP-encoding plasmid for the
identification of transfected cells (arrowheads). Scale bar = 50 μm. b
Quantification of level of AP2b1 immunofluorescence in the cell body of
neurons transfected as in a. The data are expressed as a mean value
normalized to control ± SEM. ***p < 0.001 (Kruskal-Wallis test
followed by Dunn’s multiple-comparison test). Cell images were
obtained from two independent culture batches. Number of cells per
variant (n): pSuper (22), shAP2b1#1 (23), shAP2b1#2 (18), and
shAP2b1#3 (22). c Representative confocal images of cultured
hippocampal neurons transfected on DIV8 for 4 days as indicated.
Neuron morphology was visualized by co-transfection with GFP. Scale
bar = 50 μm. d Total number of dendritic tips (TNDT) of neurons
transfected as in c. The data are expressed as a mean value normalized
to control ± SEM. ***p < 0.001 (Kruskal-Wallis test followed by Dunn’s
multiple-comparison test). Cell images were obtained from two
independent culture batches. Number of cells per variant (n): pSuper
(36), shAP2b1#1 (36), shAP2b1#2 (17), and shAP2b1#3 (37). e TNDT
of hippocampal neurons transfected on DIV8 for 4 days with a plasmids
scrambled shRNAs against AP2b1. The data are expressed as a mean
value normalized to control ± SEM. ns, nonsignificant (Kruskal-Wallis
test followed by Dunn’s multiple-comparison test). Cell images were
obtained from two independent culture batches. Number of cells per
variant (n): pSuper (25), scrAP2b1#1 (20), scrAP2b1#2 (21), and
scrAP2b1#3 (21). f Western blot analysis of α-adaptin (AP2a1) and
tubulin in protein lysates obtained from cortical neurons nucleofected
on DIV0 for 2 days with empty pSuper or a pool of pSuper plasmids
that encoded shRNAs against α-adaptin. g Results of quantitative WB
analysis of cell lysates obtained from neurons nucleofected as in f.
*p < 0.05 (one-sample t test). Number of independent experiments
(N) = 3. Error bars indicate SEM. h Representative confocal images of
cultured hippocampal neurons transfected on DIV7 for 3 days as
indicated. Neuron morphology was visualized by co-transfection with
GFP-encoding plasmid. Scale bar =50 μm. i TNDT of neurons
transfected as in h. The data are expressed as a mean value normalized
to control ± SEM. ***p < 0.001 (Mann-Whitney test). Cell images were
obtained from four independent culture batches. Number of cells per
variant (n): pSuper (78) and shAP2a1#mix (75)
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for 15 min at 37 °C in a 5 % CO2 atmosphere with anti-GluA2
primary antibody (10 μg/ml of conditioned culture medium),
rinsed with warm Neurobasal® medium, and returned to the
culture medium for an additional hour. For stimulation exper-
iments, neurons were either returned to conditioned medium
(control) or medium containing following drugs: 50 μM
AMPA + 50 μM AP5, 50 μM NDMA + 50 μM CNQX,
100 nM BDNF, or 90 mM KCl for 3 min. The neurons were
then fixed under non-permeabilizing conditions using ice-cold
4 % paraformaldehyde and 4 % sucrose in PBS for 7 min at
room temperature and washed with PBS. The surface pool of
anti-GluA2-bound receptor was detected by overnight incu-
bation at 4 °C with a saturating amount of anti-mouse Alexa
Fluor 647-conjugated secondary antibody (1:100) in ADB
buffer without Triton X-100. On the next day, after washing
in PBS, the cells were permeabilized with 0.3 % Triton X-100
in PBS for 5 min at room temperature and washed again with
PBS. Following these steps, the intracellular pool of GluA2
was detected with anti-mouse Alexa Fluor 488- or 594-
conjugated secondary antibody (1:100) in ADB buffer
Mol Neurobiol
without Triton X-100 for 1 h at room temperature, followed by
washing with PBS.
Image Acquisition and Analysis
Images of fluorescently labeled in vitro cultured cells were
acquired with a Zeiss LSM5 Exciter confocal microscope
(×40 or ×63 oil objective) or Zeiss LSM710 NLO (×20 air
or ×40 oil objective, ×1.5 zoom) at 1024 × 1024 pixel resolu-
tion. Z-stacks of the images were averaged twice per line, and
the settings were kept constant for all of the scans. The Z-
stacks were converted to single images using a maximum
intensity projection. The fluorescent intensity was measured
in soma and dendrites using ImageJ (National Institutes of
Health, Bethesda, MD) integrated density or MetaMorph
(Universal Imaging Corporation, Downingtown, PA) average
intensity options, respectively. The colocalization Colormap
plug-in for ImageJ was used for the quantification of
colocalization [37]. For the morphometric analysis, images
of transfected neurons were acquired using a Nikon TMS-F
fluorescence microscope, and the total number of dendritic
tips (TNDT) was counted manually using ImageJ Cell
Counter plug-in. Images of lentiviral vector-transduced
neurons in rat brain sections were obtained with a Zeiss
LSM710 NLO confocal microscope using a ×20 objective at
1024 × 1024 pixel resolution. Z-stacks of the images were
averaged twice per line. The obtained images were segmented
semiautomatically, and the arbors were skeletonized using the
Skeletonize 3D Fiji plug-in [38]. The skeletons were then
analyzed by the 3D Sholl analysis Fiji plug-in [39]. The linear
model (line on the graph) was fitted into empirical data (points
on the graph), and the R2 coefficient of determination was
quantified. R2 = 0.8 and 0.6 were treated as good and satisfac-
tory fits, respectively.
Total RNA Isolation for Quantitative Real-Time PCR
RNA from neurons was isolated using the RNeasy Mini Kit
(Qiagen, Venlo, The Netherlands) according to the manufac-
turer’s protocol. cDNA was obtained with High Capacity
RNA-to-cDNA Master Mix (Applied Biosystems, Foster City,
CA, USA). Real-time quantitative polymerase chain reaction
(RT-qPCR) was performed using the 7900HT Fast Real-Time
PCR System (Applied Biosystems) and SYBR Green PCR
Master Mix (Thermo Fisher Scientific) with the following
primers: GAPDH (5′-CTGTTGAAGTCACAGGAGACA and
Fig. 2 AP2 controls dendritic arbor morphology in vivo. aWestern blot
analysis of AP2b1 in protein lysates obtained from cultured hippocampal
neurons infected with Lv-Chili or Lv-Chili-shAP2b1 on DIV4 for 6 days.
b Results of quantitative WB analysis of cell lysates obtained from
neurons transduced as in a. *p < 0.05 (one-sample t test). Number of
independent experiments (N) = 4. Error bars indicate SEM. c The time-
course of the experiment. d Representative 3D reconstructions of CA1
hippocampal neurons of rats transduced with Lv-Chili or Lv-Chili-
shAP2b1 on P4 for 2 weeks. Scale bar = 100 μm. e Results of 3D
Sholl analysis of CA1 hippocampal neurons from rats treated as in b.
The data are expressed as the number of intersections as a function of
the 3D distance from the soma. R2 values = 0.8 for Lv-Chili (good fit) and
0.6 for Lv-Chili-shAP2b1 (satisfactory fit). Cell images were obtained
from eight (Lv-Chili) or five (Lv-Chili-shAP2b1) animals. Number of
cells per variant (n): Lv-Chili (28) and Lv-Chili-shAP2b1 (34)
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5′-CATCAAGAAGGTGGTGAAGCA; [40]) as the endoge-
nous control and GluA2 (5′-CACTCTCGATGCCATATACG
TTG and 5′-GCCGAGGCGAAACGAATGA; [41]) for the
target gene. The data were acquired using the SDS 2.4 and RQ
Manager 1.2.1 programs and analyzed using the 2(−ΔΔCt) meth-
od for relative quantification.
Fig. 3 In developing neurons, AP2 contributes to endocytosis of
transferrin receptor but not GluA2 under basal culture conditions. a
Representative confocal images of RAT2 fibroblasts exposed to
fluorescently labeled transferrin. Cells were electroporated for 2 days
with empty pSuper or pSuper-shAP2b1#2 (shAP2b1) and pEGFP-C1
for the identification of transfected cells (arrows). After 2 days, the cells
were starved overnight prior to 5 or 10 min fluorescently labeled
transferrin uptake. Scale bar = 20 μm. b Quantification of integrated
density of transferrin fluorescence in the cell body of RAT2 fibroblasts
transfected and treated as in a. The data are expressed as a mean value
normalized to control. Error bars indicate SEM. ***p < 0.001 (Mann-
Whitney test). Cell images were obtained from four independent culture
batches. Number of cells per variant (n): pSuper (55) and shAP2b1 (49)
for 5 min uptake and pSuper (72) and shAP2b1 (52) for 10 min uptake. c
Representative confocal images of cultured hippocampal neurons
exposed to fluorescently labeled transferrin. DIV7 neurons were
transfected (arrows) for 3 days as indicated. On DIV10, cells were
starved for 3 h prior to 5 or 10 min fluorescent transferrin uptake. Scale
bar = 10 μm. d Quantification of integrated density of transferrin
fluorescence in the cell body of neurons transfected and treated as in c.
The data are expressed as a mean value normalized to control. Error bars
indicate SEM. ***p < 0.001 (Mann-Whitney test). Cell images were
obtained from five independent culture batches. Number of cells per
variant (n): pSuper (44) and shAP2b1 (52) for 5 min uptake and pSuper
(50) and shAP2b1 (50) for 10 min uptake. e Representative confocal
images of cultured hippocampal neurons transfected as indicated on
DIV7 for 3 days and subjected to the GluA2 internalization assay. i-
GluA2, internalized pool of GluA2; s-GluA2, surface pool of GluA2.
Scale bar = 20 μm. f Quantitative analysis of integrated density of s-
GluA2 and i-GluA2 dendritic fluorescence and GluA2 internalization
index in neurons transfected and treated as in e. For s-GluA2 and i-
GluA2, the data are expressed as a mean value normalized to
control ± SEM. The internalization index was calculated using the
following formula: i-GluA2/s-GluA2 + i-GluA2. The results are
presented as a mean value normalized to control ± SEM. ns,
nonsignificant; ***p < 0.001 (Mann-Whitney test). Cell images were
obtained from five independent culture batches. Number of cells per
variant (n): pSuper (50) and shAP2b1 (48)
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In Vivo Lentiviral Injections and Preparation of Brain
Slices
The procedure was performed according to a protocol that was
approved by the 1st Ethical Committee in Warsaw, Poland (de-
cision no. 674/2015). Neonatal Wistar rats (postnatal day 4 [P4],
both sexes) were anesthetized on ice for 5min. The animals were
then placed on a support in a stereotaxic frame under a Hamilton
syringe with a manually pulled glass capillary (<50 μm diame-
ter). Afterward, 1–1.5 μl of the lentiviral vector solution was
injected into the left and right hemispheres using the following
coordinates: 2 mmmedial/lateral, 3 mm anterior/posterior, and 2
or 3 mm dorsal/ventral from lambda. After the injection, the
animals were allowed to recover on a heated pillow. Two weeks
later, the rats were intraperitoneally (IP) anesthetized with
300 mg/kg pentobarbital and transcardially perfused with PBS-
II (147mMNaCl, 2.7mMKCl, and 2mMphosphate buffer, pH
7.4) and PFA-II (4 % PFA in 0.1 M phosphate buffer, pH 7.4).
The brains were then isolated, postfixed overnight in PFA-II, and
cryopreserved with 30 % sucrose in 0.1 M phosphate buffer for
approximately 72 h. The brains were then cut into 100-μm-thick
coronal sections using a Vibrating-Blade Microtome (HM 650V,
Thermo Fisher Scientific) and collected in antifreeze medium
(15 % sucrose, 35 % ethylene glycol, 25 mM phosphate buffer
Fig. 4 AP2 regulates cellular level of GluA2. a Representative confocal
images of neurons transfected (arrows) as in Fig. 3e and
immunofluorescently stained for GluA2. Scale bar = 20 μm. b
Quantitative analysis of total level of GluA2 immunofluorescence in
neurons transfected as in Fig. 3e. The integrated density of GluA2
immunofluorescence in cell bodies of transfected cells was normalized
to that in non-transfected neurons. The data are expressed as a mean value
normalized to control. Error bars indicate SEM. ***p < 0.001 (Mann-
Whitney test). Cell images were obtained from six independent culture
batches. Number of cells per variant (n): pSuper (48) and shAP2b1 (50). c
Western blot analysis of GluA2, GluA1, and TrkB in protein lysates
obtained from cultured hippocampal neurons infected with Lv-Chili or
Lv-Chili-shAP2b1 on DIV4 for 6 days. d Results of quantitative WB
analysis. ns, nonsignificant; *p < 0.05, **p < 0.01 (one-sample t test).
Number of independent experiments (N): GluA2 (4), GluA1 (4), and
TrkB (3). Error bars indicate SEM
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[pH 7.4], and 10 mM NaF). Prior to immunostaining, brain sec-
tions were washed with PBS-II and underwent antigen retrieval
(10 mM trisodium citrate and 0.05 % Tween-20) for 15 min at
60 °C, followed by washing with PBS-II. The brain slices were
then treatedwith blocking buffer (PBS-II supplementedwith 1%
donkey serum and 1 % Triton-X-100) for 1 h at room tempera-
ture and incubated with α-RFP primary antibodies (1:250 in
blocking buffer) overnight at 4 °C. Afterward, the slices were
washed in PBS-II and incubated with Alexa Fluor 594-
conjugated secondary antibodies (1:200 in blocking buffer) for
2 h at room temperature. The brain sections were then washed
with PBS-II and counterstained with Hoechst 33258 (1 μg/ml,
1:10,000; Invitrogen).
Statistical Analysis
The exact numbers of cells (n) and culture batches (N) that
were examined for the respective experiments are provided in
the figure legends. The statistical analyses were performed
using Prism software (GraphPad, San Diego, CA). The data
were analyzed using the Kruskal-Wallis test and Dunn’s
multiple-comparison post hoc test or one-way ANOVA test
followed by Bonferroni multiple-comparison test. For com-
parisons between two groups, the Mann-Whitney test or
one-sample t test was used to verify statistical significance.
Results
AP2b1 Controls Dendritic Arbor Morphology
Although CME is important for mammalian dendritogenesis, the
direct involvement of AP2 has not been studied to date. In the
absence of AP2, the endocytosis of cargo can still occur via
alternative entry routes. Therefore, we sought to verify the role
of AP2 in dendritogenesis. First, we designed three shRNAs
against rat AP2b1, cloned them into a pSuper vector, transfected
them to DIV8 hippocampal neurons, and validated, using immu-
nofluorescence, their efficacy against endogenous AP2b1 2 days
later (Fig. 1a, b). The next series of experiments was performed
to determine whether the lower amount of AP2b1 affects proper
dendritic tree morphology in in vitro cultured neurons undergo-
ing intensive dendritogenesis. DIV8 hippocampal neurons were
transfected with plasmids encoding AP2b1 shRNAs, and the
TNDT was counted after 4 days (Fig. 1c, d). As shown in
Fig. 1d, the transfection of each AP2b1 shRNA lowered the
TNDT compared with the pSuper control. In contrast, when we
performed neuronal transfection using pSuper that encoded
scrambled sequences of used shRNAs, we did not observe any
significant changes in TNDT compared with control neurons
(Fig. 1e). These results indicate the specific effects of the tested
shAP2b1 shRNAs on the TNDT of developing neurons. The
specificity of shAP2b1#2 was further confirmed by rescue
experiments, in which DIV7 neurons were transfected with this
particular shRNA and pEGFP-AP2b1* that encoded shAP2b1-
resistant AP2b1 mRNA (EGFP-AP2b1*; Fig. 5e, f).
To further support the importance of AP2 for proper dendritic
branching, we tested whether the knockdown of AP2a1 also
leads to dendritic tree simplification. We first designed three
shRNAs against AP2a1 and validated their efficiency in
nucleofected neurons (Fig. 1f, g). Next, we transfected DIV7
hippocampal neurons with either pSuper or shAP2a1#mix, to-
gether with a GFP-encoding plasmid. Three days later, the
TNDT quantification revealed that AP2a1 knockdown led to
an approximately 50 % decrease in the TNDT (Fig. 1h, i).
These results indicate that the AP2 is indeed required for shaping
dendritic arbors in developing hippocampal neurons in vitro.
To confirm the physiological relevance of our observations,
we knocked down AP2b1 in developing hippocampal neurons
in vivo. In all of the experiments described hereafter, including
the in vivo experiments, we used shAP2b1#2 because of its best
performance (Fig. 1a, b). We first engineered a lentiviral vector
that simultaneously expressed AP2b1sh#2 and TdTomato (Lv-
Chili-AP2b1sh), which effectively infected cultured hippocam-
pal neurons and lowered their levels of AP2b1 (Fig. 2a, b). Next,
Lv-Chili (control) and Lv-Chili-AP2b1sh were introduced to the
hippocampi in P4 rats (Fig. 2c) for 2 weeks. Three-dimensional
reconstruction and the Sholl analysis of transduced cells’ dendrit-
ic arbors (Fig. 2d, e) showed that the complexity of dendritic
arbors of hippocampal neurons that were infected with Lv-
Chili-AP2b1sh was decreased compared with control neurons
that were infected with Lv-Chili.
AP2 Is Needed for Endocytosis of Transferrin Receptor
But Not GluA2 in Unstimulated Developing Neurons
After confirming that AP2 is required for the proper shape of
dendritic arbors in hippocampal neurons, we next searched for
the underlying mechanism. As a first step, we verified the
effectiveness of shAP2b1#2 in inhibiting the CME of trans-
ferrin receptor [TfR], a prototypical AP2 cargo by performing
a transferrin uptake assay in both non-neuronal cells (RAT2)
and neurons. In the first series of experiments, RAT2 cells
were electroporated with either pSuper or pSuper-
shAP2b1#2 together with GFP for 48 h, and the RAT2 cells
were serum-starved for 18 h prior to the addition of fluores-
cently labeled transferrin. The cells were fixed after 5 and
10 min of transferrin uptake, and the effectiveness of TfR
CME was monitored by recording the fluorescence level of
internalized transferrin (Fig. 3a). As shown in Fig. 3b, the
transfection of shAP2b1#2 at both time points significantly
decreased the amount of internalized transferrin compared
with control cells. Next, we repeated analogous experiments
using neurons that were transfected on DIV7 for 3 days with
either pSuper or pSuper-AP2b1sh#2 (Fig. 3c). Similar to the
effects of AP2 deficiency in RAT2 cells, AP2b1 knockdown
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in cultured neurons resulted in a significant reduction of trans-
ferrin uptake (Fig. 3d).
Several AP2 cargo (e.g., GluA2 and TrkB) contribute to
dendritogenesis [18, 19, 42]. However, oppose to endocytosis
of transferrin receptors, which is constitutive and AP2-depen-
dent, internalization of these receptors occurs at low rate and in
AP2-independent manner under basal culture conditions, at least
in mature neurons [43, 44]. But role of AP2 in internalization of
several such receptors in unstimulated, developing neurons cul-
tured in vitro was not studied thus far. Therefore, we could not
exclude a priori that disturbed internalization of AMPARs, for
example, contributes to dendritic phenotype induced by AP2b1
knockdown in such cells. Thus, to rule out or confirm such
possibility for AMPARs, we tested whether AP2b1 knockdown
affects the CME of GluA2 in immature neurons under basal
culture conditions. To do so, we performed a live internalization
assay using neurons that were transfected on DIV7 for 3 days
with pSuper or pSuper-shAP2b1#2, together with an RFP-
encoding plasmid for the identification of transfected cells. The
surface population of GluA2 (s-GluA2) was labeled in live cul-
tured hippocampal neurons with an antibody against the extra-
cellular portion of the receptor and then allowed to internalize
GluA2 (i-GluA2) under basal culture conditions for 60 min
(Fig. 3e). GluA2 internalization index in control cells and upon
AP2b1 knockdown was the same (Fig. 3f), indicating that
AP2b1 deficiency did not disturb basal GluA2 endocytosis in
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developing neurons. However, these experiments demonstrated
that shAP2b1 knockdown decreased the levels of both the sur-
face and internalized pool of GluA2 (Fig. 3f), suggesting a de-
crease in the total content of cellular GluA2. Given that GluA2
level is important for dendritogenesis of tectal and cortical neu-
rons, we decided to focus on this particular finding.
AP2 Regulates Cellular Levels of GluA2
The experiments described above suggested that AP2b1
knockdown lowers total GluA2 level in developing neurons.
To confirm that, the total amount of GluA2was determined by
GluA2 immunostaining in hippocampal neurons with AP2b1
knockdown and subsequent analysis revealed an approxi-
mately 50 % reduction (Fig. 4a, b). This observation was
further biochemically confirmed by quantitative Western blot
(qWB) in neurons that were transduced on DIV4 for 6 days
with control lentiviral vector Lv-Chili or an shAP2b1-carrying
vector (Fig. 4c, d). At the same time, GluA1 and TrkB levels
slightly increased in neurons with AP2 knockdown compared
with control cells (Fig. 4c, d).
GluA2 Is Needed for Proper AP2b1-Dependent Dendritic
Arbor Morphology
The results described to this point indicate that AP2 is needed for
the proper dendritic branching of hippocampal neurons and the
proper cellular level of GluA2. Earlier studies showed that
AMPAR subunits are needed for the dendrite growth of optic
tectal neurons [19] and cortical neurons [18]. However, no data
have been reported for hippocampal neurons. Therefore, we first
determined whether GluA2 knockdown phenocopies the effects
of AP2 knockdown. Transfection of DIV7 hippocampal neurons
for 3 days with pSuper-shGluA2 [30] caused∼50%GluA2 level
decrease and significant TNDTreduction (Fig. 5a–d), confirming
the contribution of GluA2 to the proper dendritic arbor morphol-
ogy of developing hippocampal neurons.
Next, we examined whether the negative effect of AP2b1
knockdown on dendritic trees could be rescued by GluA2 over-
expression. DIV7 hippocampal neurons were transfected with
shAP2b1#2 together with wild-type GluA2. We also used four
mutants of this AMPAR subunit, which (i) could not be delivered
to the cell surface (GluA2-ΔSP), (ii) could not stabilize at the cell
surface (GluA2-ΔC), and (iii) could not act as an active ion
channel (GluA2-Q566R and GluA2-Q581R). Cells that were
transfected with pSuper, shAP2b1#2 alone, or shAP2b1#2 in
combination with an AP2b1-shRNA-resistant construct (EGFP-
AP2b1*) served as additional controls. Three days
posttransfection, the neurons were fixed, and the TNDT was
assessed (Fig. 5e, f). Consistent with the previous experiments,
cells that were transfected with shAP2b1 alone exhibited a sig-
nificant reduction of the TNDT. The co-transfection of shAP2b1
and EGFP-AP2b1* substantially, although not completely, re-
versed the shAP2b1-induced simplification of dendritic arbors
(Fig. 5e, f) as well as GluA2 levels (Fig. 5g, h). Phenotypic
rescue was achieved almost to the same extent when shAP2b1
was co-transfected with a plasmid that encoded wild-type GluA2
(Fig. 5e–h). However, no rescue was observed when shAP2b1
shRNA was instead co-transfected with GluA2 mutants.
Altogether, the data showed that AP2b1-dependent dendritic tree
morphology deficits were rescued only by the addition of GluA2
with intact ion channel, which could be delivered to the cell
surface (Fig. 5e, f).
Lack of AP2b1 Does Not Affect Lysosomal Targeting
and Degradation of GluA2
The results described above led us to conclude that the pres-
ence of AP2b1 is critical for maintaining the amount of GluA2
that is needed for dendritic arborization. The cellular level of a
given protein is an effect of its biosynthesis and degradation.
Based on the experiments that were performed so far, we
Fig. 5 GluA2 is required for AP2b1-dependent proper dendritic arbor
morphology. a Representative confocal images of cultured hippocampal
neurons t r ans fec t ed (arrows ) on DIV7 fo r 3 days and
immunofluorescently stained as indicated. Scale bar = 20 μm. b
Quantitative analysis of total level of GluA2 immunofluorescence in
neurons transfected as in a. The integrated density of GluA2
immunofluorescence in transfected cells (cell body) was normalized to
that in non-transfected neurons. The data are expressed as a mean value
normalized to control. Error bars indicate SEM. ***p < 0.001 (Mann-
Whitney test). Cell images were obtained from four independent culture
batches. Number of cells per variant (n): pSuper (32) and shAP2b1 (32). c
Representative confocal images of cultured hippocampal neurons
transfected on DIV7 for 3 days as indicated. Neuron morphology was
visualized by co-transfection with GFP-encoding plasmid. Scale
bar = 50 μm. d Total number of dendritic tips (TNDT) of neurons
transfected as in c. The data are expressed as a mean value normalized
to control. Error bars indicate SEM. ***p < 0.001 (Mann-Whitney test).
Cell images were obtained from four independent culture batches.
Number of cells per variant (n): pSuper (40) and shGluA2 (40). e
Representative confocal images of cultured hippocampal neurons
transfected on DIV7 for 3 days as indicated. The GFP-encoding
plasmid was co-transfected to visualize neuron morphology. Scale
bar = 50 μm. f TNDT of neurons transfected as in e. The data are
expressed as a mean value normalized to control. Error bars indicate
SEM. ns, nonsignificant; ***p < 0.001, **p < 0.01, *p < 0.05 (one-
way ANOVA test followed by Bonferroni multiple-comparison test).
Cell images were obtained from three independent culture batches.
Number of cells per variant (n): all variants (30), except from pSuper
(29). g Representative confocal images of cultured hippocampal
neurons t r ans fec t ed (arrows ) on DIV7 fo r 3 days and
immunofluorescently stained as indicated. Scale bar = 20 μm. h
Quantitative analysis of total level of GluA2 immunofluorescence in
neurons transfected as in g. The integrated density of GluA2
immunofluorescence in transfected cells (cell body) was normalized to
that in non-transfected neurons. The data are expressed as a mean value
normalized to control. Error bars indicate SEM. *p < 0.05, ***p < 0.001
(Kruskal-Wallis test followed by Dunn’s multiple-comparison test). Cell
images were obtained from three independent culture batches. Number of
cells per variant (n): pSuper (32), shAP2b1 (31), shAP2b1/AP2b1* (30),
and shAP2b1/GluA2 (29)
Mol Neurobiol
could not determine which of these processes is affected in the
case of GluA2 upon AP2b1 knockdown. To determine wheth-
er the enhanced degradation of GluA2 occurs upon AP2b1
knockdown, we investigated the amount of internalized
GluA2 that reached lysosomes, which are responsible for
GluA2 degradation [45]. DIV7 neurons were transfected with
pSuper or shAP2b1#2 for 36 or 72 h, and an internalization
assay was then performed analogously to the assay described
above, with the additional step of immunofluorescently
detecting CD63, a lysosomal membrane glycoprotein
(Fig. 6a, b). At both of the tested time points, the analysis of
colocalization between internalized GluA2 and CD63 re-
vealed approximately 30–40 % overlap under control condi-
tions. Correction for random colocalization decreased GluA2
and CD63 puncta overlap to 10–15 % (Fig. S1, Online
Resource 1). Nevertheless, regardless of method used for anal-
ysis, we found nomeaningful differences between control and
experimental variants. Similar results were obtained for the
Fig. 6 Lack of AP2b1 does not influence lysosomal targeting and
degradation of GluA2. a Representative confocal images of cultured
hippocampal neurons transfected as indicated, immunofluorescently
stained for pool of internalized GluA2 (i-GluA2, green) and lysosomal
marker CD63 (magenta). Scale bar = 5 μm. b Results of colocalization
analysis of i-GluA2 with CD63 in the cell soma of neurons transfected
and treated as in a. The data are expressed as a mean value normalized to
control. Error bars indicate SEM. ns, nonsignificant (Mann-Whitney
test). Cell images were obtained from three independent culture
batches. Number of cells per variant (n): pSuper (26) and shAP2b1 (28)
for 36 h; pSuper (30) and shAP2b1 (29) for 72 h. c The time-course of the
experiment. d Representative Western blot showing GluA2 levels in
protein extracts obtained from cultured hippocampal neurons infected
with Lv-Chili (control) or Lv-Chili-shAP2b1 on DIV4 for 4 days and
treated as indicated in c. e Results of qWB analysis of GluA2
degradation in cells treated as in c. The data are expressed as a ratio of
GluA2 levels in CHX-treated neurons to untreated cells. GluA2 levels
were normalized to tubulin. ns, nonsignificant (Mann-Whitney test).
Number of independent experiments N = 3. Error bars indicate SEM
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colocalization analysis of internalized GluA2 with Rab7, a
marker of late endosomes (not shown). Therefore, increased
GluA2 lysosomal degradation could not account for the robust
decrease in GluA2 upon AP2b1 knockdown (Figs. 6b and S1,
Online Resource 1).
The above analysis implies that AP2b1 knockdown does
not elevate the degradation of GluA2 via the lysosomal path-
way. To further confirm this observation and additionally ex-
clude possible GluA2 degradation via alternative systems
(e.g., the proteasome; [46, 47]), we compared the rate of
GluA2 degradation in control and AP2b1-deficient neurons
upon protein synthesis inhibition. To accomplish this, DIV4
neurons were transduced with Lv-Chili or Lv-Chili-shAP2b1.
Three days post-infection, the cells were treated with CHX
(10 μM; Fig. 6c), and the level of GluA2 was assessed 24 h
later by qWB (Fig. 5d). However, upon protein biosynthesis
inhibition, we did not observe an increase in the degradation
of GluA2, measured as the ratio of GluA2 levels in CHX-
treated and untreated cells, in neurons that were transduced
with Lv-Chili-shAP2b1 compared with Lv-Chili-infected
neurons (Fig. 6e). Thus, we concluded that the lower amount
of GluA2 upon AP2b1 knockdown was not attributable to its
higher degradation rate.
Knockdown of AP2b1 Affects GluA2 Levels
by Controlling mTORC1 Signaling
Because degradation was not the reason for the reduction of
GluA2 levels due to AP2b1 knockdown in neurons, we inves-
tigated whether the lower amount of functional AP2 affects
GluA2 expression. RT-qPCR analysis of GluA2mRNA levels
in hippocampal neurons that were infected with Lv-Chili and
Lv-Chili-shAP2b1 revealed a significant, although relatively
mild, decrease in GluA2 mRNA upon AP2b1 knockdown
(Fig. 7a). This suggests that the observed reduction of
GluA2 was at least partially explained by the lower availabil-
ity of mRNA.
The inhibition of CME downregulates PI3K and AKT [11],
which are widely known activators of mTORC1, an important
regulator of protein translation. Therefore, we reasoned that in
our experimental model, AP2 deficiency led to the inhibition
of mTORC1 activity and a further decrease in GluA2 levels.
To test this hypothesis, we infected DIV4 neurons with an Lv-
Chili control vector or Lv-Chili-shAP2b1. Six days later, upon
AP2b1 knockdown, the levels of phosphorylated forms of two
canonical mTORC1 substrates: p70 ribosomal S6 protein ki-
nase 1 (S6K) and eukaryotic translation initiation factor 4E-
binding protein 1 (4E-BP1) decreased nearly by 50 %
(Fig. 7b, c).
Because AP2b1 deficiency negatively affected mTORC1
activity, we next investigated whether mTOR inhibition im-
pacts GluA2 levels. DIV7 hippocampal neurons were treated
with rapamycin (100 nM) for 2 days, and qWB analysis of
GluA2 protein abundance was performed (Fig. 7d). The re-
sults revealed that rapamycin treatment significantly de-
creased the level of GluA2 compared with control (Fig. 7e),
indicating that mTOR signaling is indeed involved in regulat-
ing GluA2 levels in developing neurons. It should be noted,
however, that mTORC1 inhibition, unlike AP2b1 knock-
down, decreased also GluA1 and TrkB levels (Fig. S2,
Online Resource 1). Nevertheless, in light of this finding, we
further verified whether mTORC1 mediates the impact of
AP2b1 deficiency on GluA2. Thus, we tested whether the
negative effects of shAP2b1#2 on GluA2 expression and den-
dritic trees can be rescued by the constitutively active form of
S6K (S6K1T389E [S6Kca]), the activity of which is resistant
to mTOR inhibition. DIV7 hippocampal neurons were
transfected with shAP2b1#2 together with S6Kca. Cells that
were transfected with pSuper, shAP2b1#2 alone, or
shAP2b1#2 in combination with AP2b1* served as additional
controls. As shown in Fig. 7f, g, the overexpression of S6Kca,
similar to AP2b1*, was able to counteract the shAP2b1#2-
induced decrease in GluA2 immunofluorescence. Moreover,
the partial rescue of the TNDT was also achieved when
shAP2b1 was co-transfected with a plasmid that encoded
S6Kca (Fig. 7h, i). Thus, we concluded that AP2 controlled
GluA2 levels and dendritogenesis via mTOR-S6K1 signaling.
Discussion
In the present study, we demonstrated that the AP2
adaptor complex, a critical component of the mechanism
of CME, is needed for the proper dendritic arbor mor-
phology of hippocampal neurons in vitro and in vivo.
AP2 knockdown concomitantly decreased dendritic ar-
borization and the level of the GluA2 subunit of
AMPARs. Consequently, supplementation of functional
GluA2 rescued dendritic arbor simplification that was
caused by AP2b1 knockdown. Moreover, we found that
AP2 deficiency also reduced the activity of mTOR, a
positive regulator of GluA2 synthesis. Accordingly,
overexpression of the constitutively active form of the
mTOR downstream effector S6K1 in AP2-deficient neu-
rons rescued GluA2 expression and dendritic morpholo-
gy deficits. Altogether, our findings demonstrate that
AP2 controls dendritogenesis by ensuring suitable levels
of GluA2 synthesis.
AP2 Contributes to Proper Neuronal Morphology
of Mammalian Neurons
An important finding of the present study was that the AP2
complex is required for the proper dendritic morphology of rat
hippocampal neurons, both cultured in vitro and developing
in vivo. Thus far, two cellular functions of AP2 have been
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described. AP2 plays a canonical role during CME,whenAP2
serves as an endocytic adaptor that links cargo with the
clathrin coat [5]. Recently, however, the contribution of AP2
to autophagosome formation and the degradation of selected
proteins has been described [48]. Data from Drosophila sug-
gest that disturbances in endocytosis of the adhesion molecule
Nrg that are caused by AP2 deficiency indeed lead to the
simplification of dendritic arbors [12]. These data imply that
the AP2-dependent trafficking of selected membrane proteins
contributes to dendritogenesis but it remains to be established,
disturbance of which specific cargo trafficking leads to den-
dritic growth and GluA2 synthesis inhibition upon AP2
knockdown in mammalian neurons. The list of potential can-
didates is quite long (e.g., TrkB, cholesterol receptors, neuro-
transmitter receptors). In our opinion, it will be very challeng-
ing to pinpoint specific AP2 cargo, the disrupted trafficking of
which induces changes that are specific to AP2 knockdown.
Also we cannot exclude that the observed phenotypic effects
of AP2 deficiency are not linked to inhibition of specific cargo
CME but rather stem from overall change in protein
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expression and/or cell metabolism resulting from global
change of CME. This could be potentially corroborated by
the observation that AP2b1 knockdown lowers activity of
mTORC1, a known regulator of cellular metabolism. Yet,
we show that lowering mTORC1 activity has broader effect
on protein synthesis than AP2b1 knockdown, which argue
against global changes and implies existence of more specific,
yet undiscovered, mechanism.
AP2 Controls Dendritic Arborization by Regulating
GluA2 Biosynthesis
The contribution of GluA2 to dendritogenesis of develop-
ing tectal and cortical neurons has been described [18,
19]. Several studies suggest that in mature neurons
AMPARs are internalized via CME in response to in-
creased neuronal activity [7–9, 44]. In fact, upon LTD
induction, AMPAR internalization requires interactions
with AP2 [9]. In unstimulated cells, however, AMPAR
endocytosis is relatively low and is CME- and AP2-
independent [43, 44]. But rules of GluA2 trafficking in
developing neurons have not been studied neither under
basal conditions nor upon stimulation. Therefore, we were
not able to exclude that under our experimental conditions
AP2b1 knockdown leads to disturbance of GluA2 inter-
nalization. Therefore, we studied basal GluA2 endocytosis
in young neurons. Our results clearly showed that, similar
to unstimulated mature neurons, young neurons that were
undergoing intensive dendritogenesis did not require AP2
for GluA2 internalization. However, additional experi-
ments, results of which are presented in Fig. S3, revealed
that in developing neurons standard protocols used to in-
duce internalization of AMPARs are inefficient, suggest-
ing that indeed some aspects of AMPAR trafficking differ
between developing and mature neurons.
Although we did not observe effects of AP2b1 knockdown
on GluA2 internalization in developing neurons, we found
that AP2b1 is required to sustain the cellular levels of
GluA2 that are sufficient for dendritic growth and/or mainte-
nance. This conclusion was corroborated by several observa-
tions. First, we found that AP2b1 knockdown decreased the
cellular level of GluA2. Second, GluA2 knockdown, similar
to AP2 deficiency, simplified dendritic arbors. Third and most
importantly, supplementation with functional GluA2 restrict-
ed the dendritic arbor phenotype that was caused by AP2
deficiency. These observations raise the issue of the way in
which AP2 controls GluA2 expression. Our data argue for the
lower level of GluA2 originating from its disrupted biosyn-
thesis. First, we found a slight decrease in the amount of
GluA2 mRNA upon AP2b1 knockdown. Second, our data
imply that AP2 controls GluA2 synthesis also at the level of
translation. Still, however, an open question remains how low-
er GluA2 expression translates to decreased complexity of
dendritic arbor. Hippocampal AMPARs most often work as
heterodimers (i.e., GluA1-GluA2, GluA2-GluA3), and we
showed that overexpression of fully functional GluA2 was
capable to rescue dendritic defects caused by AP2b1 knock-
down. This could mean that decreased number of dendrites
stems from lowered AMPAR-dependent transmission as both
heterodimer types should be affected by AP2b1 knockdown.
However, in certain circumstances, AMPAR subunits form
homodimers (e.g., GluA1-GluA1) [49]. Thus, it is possible
that upon AP2b1 knockdown cells start to form GluA1
homodimers to sustain AMPAR-dependent transmission.
Such switch could in turn affect dendritic calcium signaling,
which has been repeatedly shown to impact dendritogenesis
either Bpositively^ or Bnegatively^ depending on its entry
route [50]. Moreover, it was demonstrated in cortical pyrami-
dal neurons that overexpression of GluA1 (which likely favors
formation of GluA1 homodimers) was not effective in induc-
ing dendritic arborization while GluA2 overexpression stim-
ulated dendritogenesis quite potently [18]. Thus, further ex-
periments are needed to distinguish direct and indirect effects
of GluA2 deficiency on dendritic branching.
Fig. 7 AP2 controls GluA2 levels via mTORC1. aGluA2mRNA levels
in cultured hippocampal neurons infected with Lv-Chili (control) or Lv-
Chili-shAP2b1 on DIV4 for 6 days. **p < 0.01 (one-sample t test).
Number of independent experiments N = 4. Error bars indicate SEM. b
Representative Western blot showing phospho-S6K (T389) (P-S6K) and
phospho-4E-BP1 (T37/46) (P-4E-BP) levels in protein lysates obtained
from neurons infected as in a. c Results of qWB analysis of P-S6K and
P-4E-BP levels, normalized to tubulin, in protein lysates from neurons
infected as in a. ***p < 0.001, *p < 0.05 (one-sample t test). Number of
independent experimentsN = 6 (P-S6K) andN = 4 (P-4E-BP). Error bars
indicate SEM. d Representative Western blot showing levels of GluA2 in
protein extracts obtained from control DIV9 neurons or cells after 2 days
rapamycin (RAPA, 100 nM) treatment. e Results of qWB analysis of
GluA2 levels, normalized to tubulin, in protein extracts of cells treated
as in d. ***p < 0.001 (one-sample t test). Number of independent
experiments N = 5. Error bars indicate SEM. f Representative confocal
images of cultured hippocampal neurons transfected on DIV7 for 3 days
as indicated. Cells were immunofluorescently stained for GluA2. GFP
was co-transfected to identify transfected neurons (arrows). Scale
bar = 20 μm. g Quantitative analysis of total levels of GluA2
immunofluorescence in neurons transfected as in f. The integrated
density of GluA2 immunofluorescence in cell bodies of transfected
cells was normalized to that in non-transfected neurons. The data are
expressed as a mean value normalized to control. Error bars indicate
SEM. ***p < 0.001, **p < 0.01 (Kruskal-Wallis test followed by
Dunn’s multiple-comparison test). Cell images were obtained from four
independent culture batches. Number of cells per variant (n): pSuper (39),
shAP2b1 (46), shAP2b1/AP2b1* (40), and shAP2b1/S6Kca (42). h
Representative confocal images of cultured hippocampal neurons
transfected on DIV7 for 3 days as indicated. Scale bar = 50 μm. i Total
number of dendritic tips (TNDT) of neurons transfected as in h. The data
are expressed as a mean value normalized to control. Error bars indicate
SEM. ***p < 0.001, **p < 0.01 (Kruskal-Wallis test followed by Dunn’s
multiple-comparison test). Cell images were obtained from five
independent culture batches. Number of cells per variant (n): pSuper
(50), shAP2b1 (50), shAP2b1/AP2b1* (47), and shAP2b1/S6Kca (47)
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AP2 Controls GluA2 Levels via the mTORC1 Pathway
mTORC1 controls protein translation via its downstream ef-
fectors 4E-BP1 and p70S6K. In neurons, mTORC1 is in-
volved in controlling protein synthesis in response to BDNF,
insulin, and a variety of neurotransmitters [25]. mTOR, 4E-
BP1, and p70S6K also regulate dendritic arbor growth [20,
21]. Considering the previous findings and new evidence that
was provided by our study, we propose that AP2 controls
GluA2 synthesis via the mTORC1 pathway. Several findings
in the present study support this hypothesis. First, AP2b1
knockdown decreased mTORC1 pathway activation.
Second, mTOR inhibition by rapamycin lowered GluA2 pro-
tein levels. Third, overexpression of the active form of
p70S6K1 counteracted the decrease in the cellular content of
GluA2 and dendritic arbor simplification that were induced by
AP2b1 loss. However, AP2 knockdown, in contrast to
rapamycin treatment, decreased the cellular levels of GluA2
but not the levels of GluA1 or TrkB. How can the effect of
AP2b1 knockdown be so specific? In our opinion, additional
means of the regulation of protein synthesis must be consid-
ered. For example, GluA2 protein translation was predicted
and subsequently shown to be regulated by a specific set of
microRNAs [51, 52]. One of them is miR124a, which does
not recognize, for example, GluA1 [53]. Our preliminary data,
however, ruled out possibility that miR124a expression in-
creases in neurons upon AP2 knockdown (data not shown).
Therefore, future work should address how, in addition to
mTORC1 regulation, AP2 controls the expression of GluA2
so specifically and whether microRNAs other than miR124a
may be involved.
In summary, we found evidence that the AP2 adaptor com-
plex is needed for the dendritogenesis of mammalian neurons,
and mTOR-dependent GluA2 biosynthesis was a contributing
mechanism.
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